Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69 publications
Recent advances in 1,3,5-triazine-based PI3K inhibitors for cancer therapy: a comprehensive review.
Journal: Future medicinal chemistry
Published: July 04, 2026
Integrated computational and in vitro investigation to explore the preliminary anti-proliferative and anti-mitotic potential of γ-oryzanol against breast cancer.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: June 16, 2026
Deciphering the Anticancer Potential of Bifidobacterium longum MB BBLM15 Derived Postbiotic Metabolites in Cervical Cancer: In Vitro, In Silico, and Synergy Studies.
Journal: Probiotics and antimicrobial proteins
Published: April 24, 2026
Investigation of novel 4-substituted piperazine-pyrrolo[2,3-d]pyrimidine N-phenylacetamides as MELK-targeted anticancer agents for breast cancer therapy.
Journal: Bioorganic chemistry
Published: February 15, 2026
Exploring Bakuchiol as an HSP90-Targeting Lead Against Triple-Negative Breast Cancer: Evidence from In Silico, In Vitro, and Synergy Studies.
Journal: Journal of computer-aided molecular design
Published: January 01, 2026
Molecular modelling and structure-activity relationship of pyrrolo[2,3-d]pyrimidine derivatives as potent DNA gyrase B inhibitors.
Journal: Journal of biomolecular structure & dynamics
Published: December 09, 2025
Peiminine attenuates inflammatory bowel disease by suppressing TLR4 mediated NFƙB pathway: an integrated network pharmacology and experimental validation.
Journal: Scientific reports
Published: December 08, 2025
Versatile 1,2,3-Triazole Hybrids in Breast Cancer Treatment: From Molecular Mechanisms to Therapeutic Promise.
Journal: Current medicinal chemistry
Published: October 19, 2025
From in-silico QSAR modeling to in-vitro MTT assay: experimental validation of novel uPAR leads for triple-negative breast cancer (TNBC) and skin cancer.
Journal: Scientific reports
Published: October 05, 2025
Novel quinolinyl-thiazole hybrid candidates bearing N-methyl piperazine as potential anti-breast cancer agents: synthesis, biological evaluation and computational studies.
Journal: RSC advances
Published: August 26, 2025
Exploring FDA-approved small molecules for their potential as PD-1/PD-L1 inhibitors: integrating computational screening with experimental testing.
Journal: Journal of molecular modeling
Published: August 12, 2025
Last Updated: 09/26/2026